Skip to main content
. 2017 Jan 10;37(2):737–746. doi: 10.3892/or.2017.5362

Figure 1.

Figure 1.

Distribution of osteopontin (OPN), matrix metalloproteinase (MMP)-9, and MMP-9 activity markers among 53 controls and 148 melanoma cases, according to clinicopathological characteristics. Neg, negative; Pos, positive.